Surgical Science Sweden AB (publ) (SUS.ST) Stock Analysis & Winston Score

Surgical Science Sweden AB makes simulators that help surgeons and medical staff practice procedures without touching a real patient. Their main products are software-based training systems for minimally invasive surgeries, such as laparoscopy and robotic-assisted procedures. Hospitals, medical schools, and surgical training centers around the world use these simulators to train doctors before they operate on actual people. The company earns money by selling simulator hardware and software, along with licenses and service contracts. Surgical Science operates globally, with a strong presence in Europe and North America, and has grown partly through acquiring other simulation companies. Its moat comes from specialized software, regulatory approvals, and the fact that hospitals tend to stick with training systems already embedded in their programs. A key growth driver is the global expansion of robotic surgery, which increases demand for simulation-based training, though the company faces risk from low current returns on invested capital and competition from larger medical device companies entering the training market.